Amsurg Corp Raises FY 2013 EPS Guidance; Reaffirms FY 2013 Revenue Guidance; Issues Q4 2013 EPS Guidance In Line With Analysts' Estimates


Tuesday, 22 Oct 2013 04:30pm EDT 

Amsurg Corp announced that are increasing its financial guidance for fiscal 2013 earnings per share (EPS) and expects net earnings from continuing operations per diluted share attributable to common shareholders in a range of $2.19 to $2.21, excluding the impact of the deconsolidation gain, compared with the previous range of $2.17 to $2.20, excluding the impact of the deconsolidation gain. The Company affirmed its fiscal 2013 revenue guidance in a range of $1.06 billion to $1.09 billion. For the fourth quarter of 2013, the Company expects net earnings from continuing operations per diluted share attributable to common shareholders in a range of $0.56 to $0.58. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report EPS of $2.20 and revenue of $1.08 billion for fiscal 2013; and EPS of $0.57 for the fourth quarter of 2013. 

Company Quote

55.21
0.78 +1.43%
26 Dec 2014